查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356660

勃起功能障碍设备市场报告：2030 年趋势、预测与竞争分析

Erectile Dysfunction Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

勃起功能障碍设备趋势与预测

到 2030 年，全球勃起功能障碍设备市场预计将达到 29 亿美元，2024 年至 2030 年年复合成长率为 8.3%。该市场的主要驱动因素是前列腺癌患病率的增加、对用户友好的 ED 设备的需求不断增加以及由于慢性疾病和老龄化而导致的勃起功能障碍病例的增加。全球勃起功能障碍治疗设备市场未来性广阔，医院/ASC市场和诊所市场都有商机。

勃起功能障碍设备市场洞察

Lucintel 预测，由于患有与老龄化相关的前列腺癌和心血管疾病的患者对勃起功能障碍设备的需求增加，60 岁及以上的人在预测期内将出现最高的增长。预计这一目标将会实现。

由于医疗专业人员对治疗前列腺癌和勃起功能障碍患者的勃起功能障碍设备的需求不断增加，医疗保健可能仍然是最大的细分市场。

由于高科技设备和完善的医疗保健系统的可用性，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球勃起功能障碍设备市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球勃起功能障碍设备市场趋势（2018-2023）与预测（2024-2030）
  • 按年龄分類的全球勃起功能障碍设备市场
    • 不到40年
    • 40-60岁
    • 超过 60 年
  • 按产品类型分類的全球勃起功能障碍设备市场
    • 真空收缩装置
    • 阴茎植入
    • 衝击波疗法
    • 其他的
  • 按原因分類的全球勃起功能障碍设备市场
    • 血管疾病与糖尿病
    • 神经系统疾病
    • 其他的
  • 全球勃起功能障碍设备市场（依最终用途）
    • 医院和 ASC
    • 诊所

第4章2018-2030年分地区市场趋势及预测分析

  • 全球勃起功能障碍设备市场（按地区）
  • 北美勃起功能障碍设备市场
  • 欧洲勃起功能障碍设备市场
  • 亚太地区勃起功能障碍设备市场
  • 其他区域勃起功能障碍设备市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按年龄组别分類的全球勃起功能障碍设备市场成长机会
    • 全球勃起功能障碍设备市场成长机会（依产品类型）
    • 全球勃起功能障碍设备市场成长机会（按原因）
    • 全球勃起功能障碍设备市场成长机会（依最终用途）
    • 全球勃起功能障碍设备市场成长机会（按地区）
  • 全球勃起功能障碍设备市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球勃起功能障碍设备市场产能扩张
    • 全球勃起功能障碍器材市场的合併和收购企业
    • 认证和许可

第7章主要企业概况

  • Boston Scientific
  • Rigicon
  • Coloplast
  • Promedon
  • Sanofi
  • Bayer
  • Zephyr Surgical Implants
简介目录

Erectile Dysfunction Device Trends and Forecast

The future of the global erectile dysfunction device market looks promising with opportunities in the hospital & ASC and clinic markets. The global erectile dysfunction device market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are increasing prevalence of prostate cancer, growing demand for user friendly ED devices, and rising cases of erectile dysfunctional caused by chronic disease or aging.

A more than 150-page report is developed to help in your business decisions.

Erectile Dysfunction Device by Segment

The study includes a forecast for the global erectile dysfunction device by age group, product type, cause, end use, and region.

Erectile Dysfunction Device Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Less than 40 Years
  • 40-60 Years
  • More than 60 Years

Erectile Dysfunction Device Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Vacuum Constriction Devices
  • Penile Implants
  • Shockwave Therapy
  • Others

Erectile Dysfunction Device Market by Cause [Shipment Analysis by Value from 2018 to 2030]:

  • Vascular Disorders and Diabetes
  • Neurological Disorders
  • Others

Erectile Dysfunction Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and ASCs
  • Clinics

Erectile Dysfunction Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Erectile Dysfunction Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies erectile dysfunction device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the erectile dysfunction device companies profiled in this report include-

  • Boston Scientific
  • Rigicon
  • Coloplast
  • Promedon
  • Sanofi
  • Bayer
  • Zephyr Surgical Implants

Erectile Dysfunction Device Market Insights

Lucintel forecasts that more than 60 years is expected to witness highest growth over the forecast period due to growing demand for erectile dysfunction devices among patients of this age range suffering from age-related prostate cancer and CVDs.

Clinic will remain the largest segment due to growing demand for erectile dysfunction devices in this setting by healthcare professionals to treat individuals suffering from prostate cancer or erectile dysfunction issues.

North America is expected to witness highest growth over the forecast period due to significant availibility of high-tech devices and presence of well established healthcare system in this region.

Features of the Global Erectile Dysfunction Device Market

Market Size Estimates: Erectile dysfunction device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Erectile dysfunction device market by various segments, such as by age group, product type, cause, end use and region in terms of($B).

Regional Analysis: Erectile dysfunction device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different age groups, product types, causes, end uses, and region.s for the erectile dysfunction device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the erectile dysfunction device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the erectile dysfunction device market size?

Answer: The global erectile dysfunction device market is expected to reach an estimated $2.9 billion by 2030.

Q.2. What is the growth forecast for erectile dysfunction device market?

Answer: The global erectile dysfunction device market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the erectile dysfunction device market?

Answer: The major drivers for this market are increasing prevalence of prostate cancer, growing demand for user friendly ED devices, and rising cases of erectile dysfunctional caused by chronic disease or aging.

Q.4. What are the major segments for erectile dysfunction device market?

Answer: The future of the erectile dysfunction device market looks promising with opportunities in the hospital & ASC and clinic markets.

Q.5. Who are the key erectile dysfunction device market companies?

Answer: Some of the key erectile dysfunction device companies are as follows:

  • Boston Scientific
  • Rigicon
  • Coloplast
  • Promedon
  • Sanofi
  • Bayer
  • Zephyr Surgical Implants

Q.6. Which erectile dysfunction device market segment will be the largest in future?

Answer: Lucintel forecasts that more than 60 years is expected to witness highest growth over the forecast period due to growing demand for erectile dysfunction devices among patients of this age range suffering from age-related prostate cancer and CVDs.

Q.7. In erectile dysfunction device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to significant availibility of high-tech devices and presence of well established healthcare system in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the erectile dysfunction device market by age group (less than 40 years, 40-60 years, and more than 60 years), product type (vacuum constriction devices, penile implants, shockwave therapy, and others), cause (vascular disorders and diabetes, neurological disorders, and others), end use (hospitals and ASCs and clinics), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Erectile Dysfunction Device Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Erectile Dysfunction Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Erectile Dysfunction Device Market by Age Group
    • 3.3.1: Less than 40 Years
    • 3.3.2: 40-60 Years
    • 3.3.3: More than 60 Years
  • 3.4: Global Erectile Dysfunction Device Market by Product Type
    • 3.4.1: Vacuum Constriction Devices
    • 3.4.2: Penile Implants
    • 3.4.3: Shockwave Therapy
    • 3.4.4: Others
  • 3.5: Global Erectile Dysfunction Device Market by Cause
    • 3.5.1: Vascular Disorders and Diabetes
    • 3.5.2: Neurological Disorders
    • 3.5.3: Others
  • 3.6: Global Erectile Dysfunction Device Market by End Use
    • 3.6.1: Hospitals and ASCs
    • 3.6.2: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Erectile Dysfunction Device Market by Region
  • 4.2: North American Erectile Dysfunction Device Market
    • 4.2.2: North American Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics
  • 4.3: European Erectile Dysfunction Device Market
    • 4.3.1: European Erectile Dysfunction Device Market by Age Group: Less Than 40 Years, 40-60 Years, and More than 60 Years
    • 4.3.2: European Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics
  • 4.4: APAC Erectile Dysfunction Device Market
    • 4.4.1: APAC Erectile Dysfunction Device Market by Age Group: Less Than 40 Years, 40-60 Years, and More than 60 Years
    • 4.4.2: APAC Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics
  • 4.5: ROW Erectile Dysfunction Device Market
    • 4.5.1: ROW Erectile Dysfunction Device Market by Age Group: Less Than 40 Years, 40-60 Years, and More than 60 Years
    • 4.5.2: ROW Erectile Dysfunction Device Market by End Use Industry: Hospitals & ASCs and Clinics

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Erectile Dysfunction Device Market by Age Group
    • 6.1.2: Growth Opportunities for the Global Erectile Dysfunction Device Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Erectile Dysfunction Device Market by Cause
    • 6.1.4: Growth Opportunities for the Global Erectile Dysfunction Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Erectile Dysfunction Device Market by Region
  • 6.2: Emerging Trends in the Global Erectile Dysfunction Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Erectile Dysfunction Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Erectile Dysfunction Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Scientific
  • 7.2: Rigicon
  • 7.3: Coloplast
  • 7.4: Promedon
  • 7.5: Sanofi
  • 7.6: Bayer
  • 7.7: Zephyr Surgical Implants